FIELD: medicine.
SUBSTANCE: the present innovation deals with treating different diseases and traumas with the help of mesenchymal stem cells (MSC) or their differentiated offspring. MSC should be introduced as cultures obtained out of autologous or nonautologous human tissues, either intravenously or directly inside the affected organ or onto its surface. After that, it is necessary to introduce metaprogerol preparation or its chemical analog: 2-(3'-dimethylaminopropyl)-5,9,13-trimethyltetradecadien-4,8,12-ic acid either intramuscularly or onto the affected surface. The innovation improves the results of therapy due to accelerating the process of recovery even at applying minimal dosages of metaprogerol or its analog and enhancing the distribution of intensively proliferating cells in affected tissues.
EFFECT: higher efficiency of therapy.
4 cl, 5 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SURGICAL TREATMENT OF HEART DISEASES OF ISCHEMIC GENESIS | 2005 |
|
RU2361529C2 |
METHOD AND APPARATUS FOR PRODUCING AUTOLOGOUS CARDIOMYOBLASTS | 2021 |
|
RU2785449C1 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
METHOD OF CHRONIC CARDIAC INSUFFICIENCY MEDICAL TREATMENT | 2006 |
|
RU2325934C1 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF OSTEOPOROSIS | 2004 |
|
RU2265442C1 |
METHOD OF TREATING CARDIOVASCULAR DISEASE | 2023 |
|
RU2822010C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2011 |
|
RU2482823C2 |
METHOD OF TREATING PATIENTS WITH INFERTILITY CAUSED BY FIBROSCLEROTICA OR HYPOPLASTIC TRANSFORMATION OF TENDOMETRIA WITH HISTORY OF REPEATED IMPLANTATION FAILURES IN ART CYCLES | 2022 |
|
RU2809667C1 |
METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES | 2008 |
|
RU2364382C1 |
Authors
Dates
2007-06-27—Published
2005-12-26—Filed